Universitätsklinikum Schleswig-Holstein (UKSH)

Hospital


Location: Lübeck / Kiel, Germany (DE) DE

ISNI: 0000000406462097

ROR: https://ror.org/01tvm6f46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment (2014) Weigel MT, Rath K, Alkatout I, Wenners AS, Schem C, Maass N, Jonat W, Mundhenke C Journal article MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis (2014) Veldhoen S, Klink T, Geiger J, Vaith P, Glaser C, Ness T, Duwendag D, et al. Journal article Impact of radical operative treatment on the quality of life in women with vulvar cancer - A retrospective study (2014) Guenther V, Malchow B, Schubert M, Andresen L, Jochens A, Jonat W, Mundhenke C, Alkatout I Journal article Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival (2014) Reichert B, Kaltenborn A, Becker T, Schiffer M, Klempnauer J, Schrem H Journal article Accuracy of trabecular structure by HR-pQCT compared to gold standard ?CT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy (2014) Krause M, Museyko O, Breer S, Wulff B, Duckstein C, Vettorazzi E, Glueer C, et al. Journal article Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib (2014) Hanfstein B, Shlyakhto V, Lauseker M, Hehlmann R, Saussele S, Dietz C, Erben P, et al. Journal article Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5) (2014) Emons G, Gorchev G, Harter P, Wimberger P, Staehle A, Hanker L, Hilpert F, et al. Journal article Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014) Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al. Journal article Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study (2014) Fasching P, Fehm T, Kellner S, De Waal J, Rezal M, Baler B, Baake G, et al. Journal article DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways (2014) Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Sauer R, Fussl C, et al. Journal article